Sign up for free March 8 web event from University of Minnesota featuring Minnetronix experts.
Minnetronix Medical Announces Recapitalization with Altaris Capital Partners
Minnetronix announces a majority recapitalization with Altaris Capital Partners, an investment firm focused on the healthcare industry.
Minnetronix Medical Awarded National Institutes of Health Grant for Proprietary Neurapheresis Product that Removes Blood from Spinal Fluid
Fast Track Small Business Innovation Research Funding Accelerates Minnetronix’s Platform Strategy to Bring Adaptable Technology and Market-Ready Products to Customers
Minnetronix Medical Gets FDA Clearance on Innovative Neurosurgical Access Platform
Medical technology company expands on 25 years of experience with new portfolio of neuro devices, including expandable port for deep brain access.
Minnetronix Medical Names Jeremy Maniak President and CEO
Minnetronix Medical, Inc., a leading medical technology company, today announced that the company’s President, Jeremy Maniak, will succeed founder Richard Nazarian as CEO on February 1, 2020.